LUNG FOR LIFE
Working to make the world a better and SAFER PLACE
What We Do
RAISE AWARENESS
IPF is a sporadic disease, with only 100,000 recorded cases in the United States. Despite its rarity, it's essential to understand the danger IPF poses, which is why Lung for Life wants to work with you to spread information about IPF.
RAISE FUNDS
Currently, there is no cure for IPF, only treatments that slow the progression of the disease. Hopefully, we can all work together as a community to raise enough money to make the world a better place.
AID OTHERS
Although there are no cures for IPF, a few treatments are currently being tested. However, these treatments are costly. So at Lung for Life, we aim to help families in need in any way we can.
EDUCATION
We believe it's essential to be educated on a cause you're supporting. So, we make sure to find the most relevant and new information regarding IPF, IPF research, treatments, steps to a cure, etc...
OUR VISION
In April 2022, I lost my grandfather to Idiopathic Pulmonary Fibrosis. It shocked my entire family, considering he got his diagnosis only three months before his passing. We were confused as to why the diagnosis was caught later rather than early on, which is why we believe that IPF screenings shouldn't be neglected, and we promote IPF screenings in yearly physicals. Along with supporting yearly screenings, we aim to raise sufficient funding for a more successful IPF treatment with lower mortality rates or a cure. Lastly, we understand how difficult it may be to get the current treatments available, so we plan to help support families who would need help getting access to these treatments.
What is Idiopathic Pulmonary Fibrosis
What is IPF?
Idiopathic Pulmonary Fibrosis(IPF) is a disease that causes scarring in the lungs. As the word "Idiopathic" suggests, there is no known cause for IPF. However, the scarring results in stiffness in the lungs, thus making it very hard to breathe.
How many cases of IPF have been recorded?
IPF is very rare. Currently, it's been estimated that every 13-20 per 100,000 people are affected by IPF in the United States. One hundred thousand people live with IPF in the U.S., with 30,000-40,000 people diagnosed with IPF each year.
Who's mainly affected?
Recent studies have shown that IPF is most common in people between the ages of fifty and seventy. Although cases used to be more common in men, the number of cases in women is on the rise.
How does IPF affect those who've had COVID-19
Around 44.9 % of those who've had COVID-19 have developed early Idiopathic Pulmonary Fibrosis. With COVID-19's unreliability, IPF research must move to the forefront of lung disease research.
CONTACT
Lung for Life
For any general inquiries, please fill in the following contact form:
BACK TO TOP